- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive-04-01-2021
Getting on Board with Diversity: Behind the Push for More Gender Representation
April 14, 2021
Features
41
4
States and institutions are enacting mandates requiring greater inclusion of women and underrepresented groups on corporate boards; what are the key questions for pharma?
SPACs: From Fad to Fixture: COVID Sparks Greater Use of IPO Alternative
April 14, 2021
Features
41
4
The “blank-check” method has emerged as a worthwhile bet for biopharma companies looking to raise capital and go public, but will its attractiveness fade along with the pandemic?
The Challenges of Worker Qualification Management in Pharma
April 14, 2021
Back Page
41
4
Life sciences companies uniquely tasked with meeting continuous and complex compliance-reporting requirements.
The Future of Telehealth: Evolving COVID Perspectives Offer Clues
April 14, 2021
Features
41
4
New data comparing past vs. present experience with telemedicine during the pandemic uncovers insight on how patients, doctors, and payers view the market post-COVID.
Pharmaceutical Executive, April 2021 Issue (PDF)
April 14, 2021
Issue PDF
41
4
Click the title above for a link to open the Pharmaceutical Executive April 2021 issue in an interactive PDF format.
Biopharma has Wind at its Back—Are Storm Clouds on Horizon?
April 13, 2021
Finance
41
4
More capital gains and the potential strains for rest of 2021.
Years in the Making: A Repeat Recognition—Uninterrupted
April 13, 2021
Features
41
4
The Healthcare Businesswomen’s Association again names Sandra Horning its WoTY—where the pharma leader’s message of purpose and partnership takes on added resonance today.
The Power of Parity
April 13, 2021
From the Editor
41
4
Ethics and diversity on full display across pharma industry.
No Limits to Science, Or Self
April 13, 2021
Executive Profile
41
4
Building on early achievements as a research scientist and drug inventor, Rod MacKenzie, today the leader of global product development at Pfizer—and latest HBA Honorable Mentor—has devoted much of his career to helping others succeed, including advancing efforts to break down gender barriers in pharma.
In Silico in Sight as Biopharma Game-Changer
April 13, 2021
Technology
41
4
A coalition of data, computational power, and AI is bringing the full potential of in silico medicine out of the realm of science fiction.
Long-View Innovation Hopes for Pharma Policy in the EU
April 13, 2021
Global Report
41
4
Draft plan looks beyond the immediate European health challenges.
COVID’s Tactical Impact on Health Plan/Manufacturer Business
April 13, 2021
Managed Markets
41
4
Writing at the intersection of managed markets and the pharmaceutical industry.
Acting on Employee Feedback Integral to Manager Growth
April 13, 2021
Leadership
41
4
How open, two-way communication can help leaders to improve.
Pressure Mounts for FDA to Ramp Up Drug Inspections
March 10, 2021
Washington Report
41
4
Agency faces a significant backlog in the US and abroad.